Travere Therapeutics, Inc. Stock Forecast
Red day on Tuesday for Travere Therapeutics, Inc. stock after losing 2.29%
(Updated on Jul 02, 2024)
The Travere Therapeutics, Inc. stock price fell by -2.29% on the last day (Tuesday, 2nd Jul 2024) from $8.28 to $8.09. During the last trading day the stock fluctuated 3.39% from a day low at $7.96 to a day high of $8.23. The price has risen in 6 of the last 10 days and is up by 10.37% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -89 thousand shares and in total, 629 thousand shares were bought and sold for approximately $5.09 million.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $8.31 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 28.00% during the next 3 months and, with a 90% probability hold a price between $8.42 and $10.64 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TVTX Signals & Forecast
The Travere Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $8.12. On a fall, the stock will find some support from the long-term average at approximately $7.19. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 01, 2024, and so far it has fallen -2.29%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $7.31 and $6.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Travere Therapeutics, Inc. finds support just below today's level at $7.31. If this is broken, then the next support from accumulated volume will be at $6.95 and $6.67.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.270 between high and low, or 3.39%. For the last week, the stock has had daily average volatility of 5.02%.
Our recommended stop-loss: $7.73 (-4.40%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (TVTX) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Travere Therapeutics, Inc. to open at $8.09, and during the day (based on 14 day Average True Range), to move between $7.66 and $8.52, which gives a possible trading interval of +/-$0.430 (+/-5.31%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 10.62% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $8.22 (1.61%) than the support at $7.31 (9.64%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Travere Therapeutics, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.
Current score: 2.624 Buy Candidate Unchanged
Predicted Opening Price for Travere Therapeutics, Inc. of Wednesday, July 3, 2024
| Fair opening price July 3, 2024 | Current price |
|---|---|
| $8.09 ( 0.0412%) | $8.09 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TVTX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.36 | 3.38% |
| R2 | 8.26 | 2.10% |
| R1 | 8.20 | 1.32% |
| Price | 8.09 | |
| S1 | 7.99 | -1.23% |
| S2 | 7.93 | -2.02% |
| S3 | 7.82 | -3.30% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.28 | 2.35% |
| R2 | 8.25 | 1.98% |
| R1 | 8.22 | 1.61% |
| Price | 8.09 | |
| S1 | 7.31 | -9.64% |
| S2 | 6.95 | -14.09% |
| S3 | 6.67 | -17.55% |
FAQ
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.
